US2011218647A1PendingUtilityA1
Medical implant
Est. expiryJul 16, 2028(~2 yrs left)· nominal 20-yr term from priority
Inventors:Donald Eagland
A61L 2430/06A61L 27/446A61L 27/16
50
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A cartilage plug ( 14 ) comprises cross-linked polyvinylalcohol, a polyvinylalcohol fibre and fumed silica. The plug may also include chondrocytes and/or hyaluronic acid.
Claims
exact text as granted — not AI-modified1 . A medical implant comprising a polymeric material and a fibrous filler.
2 . An implant according to claim 1 , said implant including at least 65 wt % water and said polymeric material comprising a hydrogel.
3 . An implant according to claim 2 , wherein said hydrogel comprises an optionally derivatised hydrophilic polymer.
4 . An implant according to claim 3 , where said hydrophilic polymer is selected from polymethacrylic acid polymers, polyimides, polyvinylalcohol and copolymers of any of the aforesaid.
5 . An implant according to claim 3 , wherein said hydrophilic polymer includes both carbonyl moieties and hydroxyl moieties.
6 . An implant according to claim 2 , wherein said hydrogel comprises an optionally derivatised polyvinylalcohol.
7 . An implant according to claim 2 , wherein said hydrophilic polymer of said hydrogel is cross-linked by a cross-linking means which preferably comprises a second polymeric material which includes a repeat unit of formula
wherein A and B are the same or different, are selected from optionally-substituted aromatic and heteroaromatic groups and at least one comprises a relatively polar atom or group and R 1 and R 2 independently comprise relatively non-polar atoms or groups.
8 . An implant according to claim 1 , wherein said fibrous filler comprises an optionally cross-linked hydrophilic polymer.
9 . An implant according to claim 8 , wherein said hydrogel includes an optionally cross-linked hydrophilic polymer and said fibrous filler comprises the same optionally cross-linked hydrophilic polymer.
10 . An implant according to claim 1 , wherein said fibrous filler comprises optionally derivatised polyvinylalcohol fibres.
11 . An implant according to claim 8 , wherein the ratio of the weight of hydrogel on a dry-matter basis to the weight of fibrous filler on a dry-matter basis is at least 1.
12 . An implant according to claim 2 , wherein the wt % of hydrogel in said medical implant on a dry-matter basis is at least 40 wt % and less than 80 wt % and the weight % of fibrous filler in said medical implant on a dry-matter basis is at least 10 wt % and is less than 40 wt.
13 . An implant according to claim 1 , which includes a non-hydrous filler, for example silica.
14 . An implant according to claim 1 , wherein the Youngs Modulus of said medical implant in a linear elastic region, for example between 0.75 MPa and 1.0 MPa, is at least 15 MPa; and the medical implant has a coefficient of friction of less than 0.1 N.
15 . An implant according to claim 1 which comprises a cartilage plug.
16 . An implant according to claim 1 which includes chondrocytes.
17 . An implant according to claim 1 , which includes hyaluronic acid or a precursor or derivative thereof.
18 . A medical implant which incorporates hyaluronic acid or a precursor or derivative thereof.
19 . A method of making a medical implant according to claim 1 , for example for replacing defective cartilage, the method comprising selecting a mixture comprising a fibrous filler together with a hydrogel or precursor of a hydrogel, introducing said mixture into a mould shaped to define said implant, allowing the mixture to cure, and removing the cured mixture from said mould.
20 . A method of treating or repairing a defect in a human body, for example for replacing defective cartilage, the method comprising introducing an implant according to claim 1 into said human body in order to treat or repair the defect.
21 . The use of an implant according to claim 1 for treating or repairing a defect in a human body.
22 . A medical implant according to claim 1 for use in treating or repairing a defect in a human body, for example for replacing defective cartilage.Join the waitlist — get patent alerts
Track US2011218647A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.